Results 251 to 260 of about 310,541 (331)

Frailty in Hepatocellular Carcinoma: An Unsettled Clinical Challenge. [PDF]

Curr Oncol
Bonato A, Guerra P, Vitale A, Martini A, Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest Group.   +4 more
europepmc   +1 more source

Rodent monocyte‐derived macrophages do not express CD163: Comparative analysis using macrophages from living boreoeutherians

Developmental Dynamics, EarlyView.
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito, Yukio Fujiwara, Yasuka L. Yamaguchi, Satomi S. Tanaka, Kyoko Miura, Yoshiyuki Hizukuri, Kyoko Yamashiro, Yasuhiro Hayashi, Yuta Nakashima, Yoshihiro Komohara   +9 more
wiley   +1 more source

The Role of Aurora Kinase A in HBV-Associated Hepatocellular Carcinomas: A Molecular and Immunohistochemical Study. [PDF]

Diagnostics (Basel)
Huz M, Karadag Soylu N, Koc A, Kucukakcali Z, Danis N, Ozhan O.   +5 more
europepmc   +1 more source

Advanced extracellular vesicle immunotherapy

FlexMat, EarlyView.
A diagrammatic depiction of the therapeutic applicability of extracellular vesicles (EVs) in immunotherapy. This review explores the dual roles of tumor‐derived and immune cell‐derived EVs in cancer immunotherapy, discusses recent progress in EV engineering that improve their clinical utility, and evaluates their potential to augment existing ...
Jingjing Zhang, Yunfei Mu, Xianyue Ji, Xiaoting Jiang, Ruiheng Wang, Xianguang Ding, Lianhui Wang   +6 more
wiley   +1 more source

Disrupted Vitamin D Metabolism in Hepatocellular Carcinoma: Free and Bioavailable 25(OH)D as Novel Biomarkers of Hepatic Reserve and Clinical Risk. [PDF]

Molecules
Osredkar J, Rakusa M, Jerin A, Štabuc B, Zaplotnik M, Štupar S, Siuka D.   +6 more
europepmc   +1 more source

CX3CR1+ macrophages interact with HSCs to promote HCC through CD8+ T-cell suppression

Jong‐Min Jeong, Sung Eun Choi, Young‐Ri Shim, Hee‐Hoon Kim, Young‐Sun Lee, Keungmo Yang, Kyurae Kim, Min Jeong Kim, Katherine Po Sin Chung, Seok‐Hwan Kim, Jin‐Seok Byun, Hyuk Soo Eun, Won‐Il Jeong   +12 more
openalex   +1 more source

Loss of two-pore channel 2 enhances CD8+ T cell cytotoxicity and directly impairs tumour growth via MAPK axis in HCC [PDF]

Lina Ouologuem, André Kübler, Sarah Ouologuem, Amar Hadzic, Jan B. Stöckl, Anna Chiara Siciliano, Stefania Forciniti, Salvatore Nigro, Helena Iuele, Valentina Onesto, Anny Nguyen, Dana Matzek, Carla Abrahamian, Christian Grimm, Bastian Popper, Giuseppe Gigli, Loretta L. del Mercato, Olivia M. Merkel, Thomas Fröhlich, Sebastian Theurich, Karin Bartel   +20 more
openalex   +1 more source

Retrospective Analysis of Diagnostic and Prognostic Value of Serum Glypican-3 in Patients With HCV-Related Cirrhosis With Or Without HCC After Achieving SVR With DAA Treatment. [PDF]

J Gastrointest Cancer
Caviglia GP, Guariglia M, Gaia S, Troshina Y, Rolle E, Saba F, Dileo E, Carucci P, Ciancio A.   +8 more
europepmc   +1 more source